Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €90.44 EUR
Change Today +0.40 / 0.44%
Volume 3.2M
SAN On Other Exchanges
Symbol
Exchange
EN Paris
EN Paris
New York
OTC US
BrsaItaliana
Mexico
EN Paris
Frankfurt
Frankfurt
NASDAQ GM
As of 11:35 AM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert Castaigne

Independent Director and Chairman of Audit Committee, Sanofi
AgeTotal Calculated CompensationThis person is connected to 95 board members in 7 different organizations across 10 different industries.

See Board Relationships
67--

Background*

Mr. Robert Castaigne served as the Chief Financial Officer of TOTAL S.A. (formerly, Total Fina Elf S.A.) from 1994 to June 1, 2008, Officer since 1990 and also served as its Executive Vice President until June 1, 2008. Mr. Castaigne started his career at TOTAL in 1972, where he served as an Engineer since January 1, 1972 and as Departmental Head within the Economic Division until 1977. He served as the Head of The Exploration-Production subsidiaries at TOTAL from 1977 ...

Read Full Background

Corporate Headquarters*

54, Rue La Boétie
Paris, Ile-de-France 75008

France

Phone: 33 1 53 77 40 00
Fax: 33 1 53 77 42 96

Board Members Memberships*

Director
Director
Director and Member of Audit Committee
1992-2004
Former Director
1999-N/A
Former Director
2000-Present
Independent Director and Chairman of Audit Committee
2007-Present
Director, President of Remuneration Committee and Member of Audit Committee
2008-N/A
Independent Non-Executive director and Member of Audit Committee
2009-Present
Independent Director and Member of Audit, Internal Control & Risk Committee
2015-Present
Independent Director, Chairman of Compensation & Nomination Committee and Member of Audit Committee

Education*

Unknown/Other Education
Ecole Nationale Superieur du Petrole et des Moteurs
Unknown/Other Education
Ecole Centrale des Techniques de l'Environnement Industriel
Doctorate
University of Paris I--Sorbonne

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SAN:FP €90.44 EUR +0.40

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$916.0K
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€3.2M
Andrew Philip Witty Chief Executive Officer, Executive Director and Member of Finance Committee
GlaxoSmithKline plc
2.0M GBP
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANOFI, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.